Almaden Genomics and BigOmics Collaborate to Provide End-to-End Omics Data Analysis
February 22, 2024
DALLAS – Almaden Genomics has teamed with BigOmics Analytics to integrate Omics Playground with g.nome®, Almaden’s cloud-native omics data science solution to provide end-to-end analysis. While g.nome facilitates effortless iteration in data processing and analysis, allowing researchers to explore their results with complete traceability and reproducibility, Omics Playground is a data discovery platform that enables researchers [...]
February 22, 2024
BROOKLYN, N.Y. -- Opentrons Labworks, Inc., a leader in lab automation and makers of accessible lab robotics, today announced the appointment of Gregory Cole, PhD as Chief Innovation Officer. With over a decade of medical robotics, IP strategy, and product commercialization expertise, Dr. Cole will be responsible for establishing commercial and academic partnerships with leading [...]
LabVantage Introduces a Digitally Native Ecosystem to Boost Speed and Success in R&D Laboratories
February 22, 2024
Somerset, NJ – LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services, including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, has made available its semantic search (AILANI), advanced analytics, and LIMS solutions in an integrated, digitally native ecosystem capable of seamlessly supporting R&D laboratory [...]
February 22, 2024
Multidisciplinary Team Expected to Provide Strategic Guidance and Direction for Hitachi High-Tech America’s Molecular Research and Development Division Santa Clara, CA — Hitachi High-Tech America, Inc. (HTA) announced it has assembled a group of scientific and industry experts to form a Scientific Advisory Board (SAB). The formation of HTA’s SAB follows strategic investments by HTA’s [...]
February 22, 2024
Oxford Instruments Asylum Research today announces the release of new features for the Jupiter XR atomic force microscope (AFM) to increase productivity and improve usability. The Jupiter AFM will now include a side-view camera that provides a direct high-resolution view of the AFM tip – sample separation during tool setup which dramatically improves usability and reduces the [...]
Danaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction Targets
February 22, 2024
WASHINGTON -- Danaher Corporation (NYSE: DHR) (Danaher) announced today it has committed to set science-based greenhouse gas (GHG) emission reduction targets in line with the Science Based Targets initiative (SBTi), including a long-term target to reach net-zero value chain emissions by no later than 2050. Danaher's pledge encompasses Scope 1, 2 and 3 GHG emissions and complements [...]
INDIGO Biosciences Releases a Family of Cell-Based Reporter Assays for the Adrenergic Receptors
February 21, 2024
New Assays Include ADRA1A, ADRA1B, ADRA1D, ADRB1, and ADRB2 for Preclinical Research of Heart Failure, Hypertension, Obesity, and Respiratory Conditions STATE COLLEGE, PA, USA -- INDIGO Biosciences announced today the release of new cell-based reporter assays for the family of Human Adrenergic Receptors, including ADRA1A, ADRA1B, ADRA1D, ADRB1, and ADRB2. “INDIGO is very pleased to [...]
February 21, 2024
Companies agree to make Plasmion SICRIT® ion source compatible with Waters ACQUITY™ QDa™ Detector and SELECT SERIES™ Cyclic IMS™ mass spectrometers Augsburg – Plasmion has announced it has signed a co-marketing and co-promotion agreement with Waters Corporation to enhance analytical technologies used in scientific laboratories and Applied Markets, to help advance human health and well-being. [...]
February 21, 2024
SANTA CLARA, Calif.--Agilent Technologies Inc. (NYSE: A) today announced that Padraig McDonnell, president of the Agilent CrossLab Group (ACG), has been named CEO-elect and chief operating officer (COO) of the company, succeeding current President and CEO Mike McMullen who will retire. McDonnell will become Agilent’s president and CEO and join Agilent’s Board of Directors on [...]
February 21, 2024
Cambridge, UK – Cresset, an innovative provider of integrated in silico solutions for drug discovery announces a collaboration with Enamine, the world’s leading provider of chemical building blocks and drug discovery services to develop innovative new solutions for the early drug discovery process. The newly announced collaboration involves the development of groundbreaking technology to enable the [...]

